Clinical trial Recruiting at 4 sites Observational Ages 21 and up Women only

Evaluating the Gynecare TVT ABBREVO® Continence System for treating urinary incontinence in women

Official title: A Long Term Prospective Post Market Clinical Follow-up (PMCF) of the GYNECARE TVT ABBREVO® Continence System for the Treatment of Stress Urinary Incontinence

Run by Ethicon, Inc. · NCT04829357 · Data updated 2026-11-12

This study is testing the Gynecare TVT ABBREVO® system to see if it helps women with stress urinary incontinence feel better after surgery.

More Stress Urinary Incontinence trials

Quick facts

Study typeObservational
Ages21 Years and up
SexWomen only
Enrollment195 (estimated)
SponsorEthicon, Inc.
Industry-sponsored
Locations4 sites (North Wales, Pennsylvania and 3 other locations)
StatusRecruiting
StartedSeptember 9, 2021
Main results expectedDecember 31, 2033
Study endsDecember 31, 2038
Registry record updatedJuly 6, 2026
Trial IDNCT04829357 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women aged 21 and older who have been diagnosed with stress urinary incontinence and are planning to undergo mid-urethral sling surgery.

Probably not a fit

Patients with physical or psychological conditions that impair their ability to participate in the study or complete required assessments will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the performance of the Gynecare TVT ABBREVO® Continence System in women who are undergoing mid-urethral sling surgery for stress urinary incontinence (SUI). It involves a single-arm approach where eligible participants will be monitored post-surgery to evaluate the effectiveness of the continence system. The study will include women aged 21 and older who have been diagnosed with SUI and are planning to undergo surgical treatment without additional prolapse surgery. Participants will be required to provide informed consent and participate in follow-up assessments.

Why it matters

Potential benefit: If successful, this study could improve treatment options for women suffering from stress urinary incontinence.

How similar studies have gone: Other studies on mid-urethral sling systems have shown promising results, indicating that this approach is supported by prior research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Subjects who satisfy all of the following criteria will be considered eligible for enrollment in this study:

1. Stress urinary incontinence symptoms
2. Diagnostic evaluation, a positive cough stress rest, to confirm diagnosis of stress urinary incontinence.
3. Female subjects ≥ 21 years of age requiring treatment of SUI
4. Desired surgical correction of stress urinary incontinence using synthetic sub-urethral vaginal slings
5. Planned surgery for primary stress incontinence without concomitant prolapse surgery
6. Patient able and willing to participate in follow-up
7. Subject or authorized representative has signed the approved informed consent

Exclusion Criteria

Subjects meeting any of the following criteria will be considered not eligible for enrollment in this study:

1. Physical or psychological condition which would impair study participation or are unwilling or unable to participate in all required study visits and are unable to complete the questionnaires
2. Any pre-operative or intra-operative findings identified by the surgeon that may preclude the use of study product
3. History of previous synthetic, biologic or fascial sub-urethral sling
4. Pregnancy or plans for future pregnancy
5. History of bleeding diathesis or current anti-coagulation therapy which cannot be suspended peri-operatively according to site's standard practice.
6. Current genitourinary fistula or urethral diverticulum
7. Reversible cause of incontinence (i.e. drug effect)
8. Contraindication to surgery

Where it's running

  • Institute for Female Pelvic Medicine
    North Wales, Pennsylvania, United States
    Recruiting
  • Bio-Medical University Rome
    Rome, Italy
    Recruiting
  • Ospedale San Pietro Fatebenefratelli
    Rome, Italy
    Recruiting
  • Ospedale Regionale Beata Vergine
    Mendrisio, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.